Percutaneous transabdominal approach for the treatment of endoleaks after endovascular repair of infrarenal abdominal aortic aneurysm.

The purpose of this study was to evaluate the technical feasibility and clinical efficacy of percutaneous transabdominal treatment of endoleaks after endovascular aneurysm repair.
Between 2000 and 2007, six patients with type I (n = 4) or II (n = 2) endoleaks were treated by the percutaneous transabdominal approach using embolization with N-butyl cyanoacrylate with or without coils. Five patients underwent a single session and one patient had two sessions of embolization. The median time between aneurysm repair and endoleak treatment was 25.5 months (range: 0-84 months). Follow-up CT images were evaluated for changes in the size and shape of the aneurysm sac and presence or resolution of endoleaks. The median follow-up after endoleak treatment was 16.4 months (range: 0-37 months)
Technical success was achieved in all six patients. Clinical success was achieved in four patients with complete resolution of the endoleak confirmed by follow-up CT. Clinical failure was observed in two patients. One eventually underwent surgical conversion, and the other was lost to follow-up. There were no procedure-related complications.
The percutaneous transabdominal approach for the treatment of type I or II endoleaks, after endovascular aneurysm repair, is an alternative method when conventional endovascular methods have failed.
AuthorsSun Young Choi, Jong Yun Won, Do Yun Lee, Donghoon Choi, Won-Heum Shim, Kwang-Hun Lee
JournalKorean journal of radiology (Korean J Radiol) 2010 Jan-Feb Vol. 11 Issue 1 Pg. 107-14 ISSN: 2005-8330 [Electronic] Korea (South)
PMID20046501 (Publication Type: Journal Article)
Chemical References
  • Enbucrilate
  • Aged
  • Aged, 80 and over
  • Aortic Aneurysm, Abdominal (surgery)
  • Blood Vessel Prosthesis Implantation
  • Embolization, Therapeutic (methods)
  • Enbucrilate (administration & dosage)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications (therapy)
  • Punctures
  • Stents

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: